Summary & Overview
CPT 47381: Open Cryosurgical Ablation of Liver Tumors
CPT code 47381 denotes open cryosurgical ablation of one or more liver tumors, a surgical ablative technique performed through an open abdominal approach. Nationally, this code captures complex operative management of hepatic neoplasms where cryoablation is selected for tumor destruction, often in settings where percutaneous or laparoscopic techniques are not suitable. The code matters for hospitals and surgical teams because it reflects a resource-intensive inpatient or operating-room procedure with implications for perioperative care, anesthesia, and post-procedural monitoring.
Key payers addressed in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context and typical sites of service, plus benchmarking elements relevant to reimbursement and utilization where available. The publication outlines common billing considerations, associated modifiers, and potential policy or coverage influence on coding and payment. It also highlights areas where data was not available in the input and notes where readers should consult payer-specific policies for coverage criteria and documentation requirements.
This summary is intended for revenue cycle leaders, surgical coders, and policy analysts seeking a national-level briefing on the clinical and billing identity of CPT code 47381 and what to expect when this procedure is billed across major payers.
Billing Code Overview
CPT code 47381 describes open cryosurgical ablation of one or more liver tumors. The procedure involves surgically exposing the liver through an open approach and applying cryotherapy to ablate hepatic tumor tissue by freezing.
Service type: Ablative surgical procedure (open cryoablation)
Typical site of service: Hospital operating room or inpatient surgical setting
Clinical & Coding Specifications
Clinical Context
A 62-year-old patient with a history of colorectal cancer presents with one or more metastatic hepatic lesions identified on imaging (contrast-enhanced CT or MRI). The multidisciplinary tumor board recommends surgical management because lesions are accessible via laparotomy and the patient is an appropriate operative candidate. In the operating room under general anesthesia, the surgical team performs an open hepatic cryoablation: after laparotomy and mobilization of the liver, intraoperative ultrasound localizes the tumors, cryoprobes are placed into each lesion, and freeze–thaw cycles are performed to achieve tumor necrosis. Hemostasis is confirmed, and the abdomen is closed. Typical perioperative workflow includes preoperative imaging and labs, anesthesia evaluation, intraoperative ultrasound guidance, placement of cryotherapy probes through the open incision, intraoperative pathology consultation if needed, and postoperative monitoring on a surgical ward or step-down unit. This procedure is coded with 47381 for open cryosurgical ablation of one or more liver tumors and is typically performed in an inpatient hospital setting or an ambulatory surgery center when admission is not required. Common clinical indications include primary hepatocellular carcinoma not amenable to resection, solitary or limited liver metastases (for example from colorectal primaries), and palliative control of symptomatic hepatic tumors.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 |